Edition:
United Kingdom

GTX Inc (GTXI.OQ)

GTXI.OQ on NASDAQ Stock Exchange Capital Market

12.59USD
12 Dec 2017
Change (% chg)

$-0.21 (-1.64%)
Prev Close
$12.80
Open
$12.97
Day's High
$12.99
Day's Low
$12.59
Volume
5,292
Avg. Vol
7,714
52-wk High
$13.30
52-wk Low
$2.77

Select another date:

Tue, Nov 14 2017

BRIEF-GTX reports qtrly ‍loss per share $0.53​

* GTX provides corporate update and reports third quarter 2017 financial results

BRIEF-GTX Inc files for offering of up to 8.8 million shares of common stock

* GTX Inc files for offering of up to 8.8 million shares of common stock by the selling stockholders Source text: (http://bit.ly/2zotwFH) Further company coverage:

BRIEF-Amzak Health Investors Llc reports 6.15 pct passive stake in GTX as of Sept 29

* Amzak Health Investors Llc reports 6.15 percent passive stake in GTX Inc as of September 29 - SEC Filing‍​ Source text: (http://bit.ly/2zdLcEN) Further company coverage:

BRIEF-Aisling capital IV LP reports 6.2 pct passive stake in GTX as of Sept 29

* Aisling Capital IV LP reports 6.2 percent passive stake in GTX Inc as of Sept 29 - SEC Filing Source text: (http://bit.ly/2xW9yVO) Further company coverage:

BRIEF-Gtx announces closing of $48.5 million private placement

* Gtx announces closing of $48.5 million private placement Source text for Eikon: Further company coverage:

BRIEF-GTx announces $48.5 million private placement

* GTx - ‍entered into agreement for sale of its common stock & warrants to purchase common stock in private placement with gross proceeds of $48.5 million

BRIEF-GTx announces positive results from enobosarm Phase 2 proof-of-concept clinical trial

* GTx announces positive results from enobosarm phase 2 proof-of-concept clinical trial in women with stress urinary incontinence

BRIEF-GTx Q2 loss per share $0.40

* Gtx provides corporate update and reports second quarter 2017 financial results

Select another date: